Actos, a Prescription Drug for Type 2 Diabetes:
Actos (Pioglitazone) is an oral prescription drug manufactured by Takeda Pharmaceutical Company. It was first approved by the FDA in 1999, and has been prescribed to treat millions of adults with Type 2 diabetes. Actos works in conjunction with diet and exercise to control blood sugar levels. Patients may have been prescribed this medication under the brand name Actos, or as a combination medication under the brand names Actoplus MET, Actoplus MET XR, or Duetact.
Actos and the Risk of Bladder Cancer:
There are some very serious risks associated with Actos and Actos combination drugs, including liver damage, heart failure, and the risk of bladder cancer. Recently, alarming studies on the increased risk of bladder cancer and Actos have been a cause of concern among many. While Actos has risen as the dominant Pioglitazone-based diabetes medication, bladder cancer is the fifth most common cancer in the United States.
In 2011, the FDA conducted an interim review of an ongoing 10-year Actos study, which indicated that exposure to Actos for 12-24 months may increase the risk of bladder cancer up to 30 percent, with the risk increasing to 50 percent for those exposed to Actos over 24 months. In the summer of 2011, the FDA released a safety warning regarding Actos and its possible link to bladder cancer. The FDA also required changes to the Actos drug label, requiring the label to disclose detailed information about the possible connection to bladder cancer.
The sale of Actos was suspended in the summer of 2011 in France, while Germany's Federal Institute for Drugs and Medical Devices similarly advised doctors to discontinue Actos prescriptions pending additional investigation. In early 2012, another study published in the British Medical Journal similarly confirmed that one's risk for bladder cancer nearly doubled after taking Actos for over two years. Despite these recent studies, and the risk of personal injury lawsuits Actos remains on the market and has not been recalled in the US at this time.
Help for Those Who May Be At Risk:
Those who are taking Actos and who are experiencing symptoms of bladder cancer should contact their physician immediately. Symptoms of bladder cancer may include:
- Abdominal and lower back pain
- Blood in urine
- Pain while urinating
- Frequent urge to urinate
If you or someone you know took Actos for the treatment of Type 2 diabetes and have developed with bladder cancer, you may have cause to file a lawsuit against the Actos manufacturer Takeda Pharmaceuticals. A drug manufacturing company has a legal and ethical obligation to provide effective, tested drugs with adequate warnings. The public deserves the right to make well-informed decisions about the prescription drugs available to them, and to be protected from unknown dangers hidden within drugs.
Call us at 858-480-6182 today
If you have been harmed by Actos, our attorneys at O'Mara & Padilla would like to assist you in exploring and understanding your legal rights. In California as in many other states, the legal deadline (statute of limitations) to file personal injury lawsuits or product liability claims is 2 years from the date of injury, or 2 years from the date the injury could reasonably have been discovered. As such, we invite you to contact our office at your earliest convenience for a free legal consultation. We will promptly and thoroughly evaluate your case, and are accepting Actos cases on a contingency fee basis.